Investing
Top Analyst Upgrades & Downgrades (AMGN, CS, BEAT, DV, MAR, MSFT, RIMM, SPWRA, TOL)
Published:
These are among the top research calls and analyst upgrades and downgrades we have seen early this Friday morning with over two hours until the open:
Amgen (AMGN) Raised to Outperform at Baird.
Credit Suisse (CS) Raised to Neutral at UBS.
CardioNet (BEAT) Started as Underperform at Jefferies.
Devry (DV) Cut to Neutral at Baird.
Marriott (MAR) Cut to Market Perform at FBR.
Microsoft (MSFT) Raised to Overweight at Morgan Stanley.
Research In Motion (RIMM) Raised to Buy at Citigroup.
Sunpower (SPWRA) Cut to Sell from Neutral at Merriman Curhan Ford.
Toll Brothers Inc. (TOL) Cut to Market Perform at KBW.
JON C. OGG
It’s Your Money, Your Future—Own It (sponsor)
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.